What people actually ask about Foundayo
Forums and communities like Reddit's r/FoundayoPill fill up fast with the questions official leaflets never quite answer. We've gathered the themes that come up again and again from early users worldwide and answered each one honestly, using the published evidence and official UK information.
Last verified: 12 August 2026
A quick honesty note
Community experiences are real and valuable, but they're anecdotes, not evidence, and the loudest voices online are rarely the average experience. We use community discussion to find the questions, then answer them from trials and official sources. Nothing here is personal medical advice; your prescriber knows your history and we don't.
"When does the nausea peak, and does it go away?"
The most asked question by a mile. The consistent pattern, in trials and in community reports alike, is that nausea clusters around starting the medicine and each move up the dose ladder, then fades over days to a few weeks as your body adjusts. Users often describe it as unpredictable background queasiness, a bit like mild motion sickness, with sharper waves after large or rich meals. For most people it's mild to moderate; roughly 4% of trial participants had severe nausea or vomiting. If a dose step hits hard, prescribers can hold you there longer or step back down, which usually settles it.
"Is the nausea worse than on the Wegovy pill?"
Some users switching between oral GLP-1s report finding Foundayo's nausea stronger; others say the opposite. There's no head-to-head trial between orforglipron and oral semaglutide, so honest answer: nobody can tell you which you'd tolerate better. What is documented is each medicine's own trial data, and both show the same gut-heavy profile with most effects mild to moderate. Our sister site Ogovy covers the Wegovy pill's numbers if you want to compare like for like.
"Why am I so tired?"
Fatigue is one of the most discussed parts of the adjustment period. Tiredness is on the official side effect list, but the practical driver for many people is simply eating much less, sometimes far less, than their body is used to, and often drinking less too because thirst quietens along with appetite. The community consensus that matches the clinical advice: don't skip meals entirely, prioritise protein, and treat hydration as a scheduled task. If exhaustion is severe or persistent, that's a prescriber conversation.
"My appetite has vanished. Should I force myself to eat?"
The silencing of "food noise" is the effect people find most striking, and sometimes unsettling. You shouldn't force large meals, but you do need regular nutrition: small, protein-forward meals protect your energy, your muscle mass and your hair through rapid weight loss. Eating almost nothing accelerates fatigue, dizziness and shedding, and it isn't the goal of treatment.
"What's actually helping people with the constipation?"
The unglamorous big one. Three things come up constantly and all match standard advice: fibre increased gradually (sudden fibre on a slowed gut backfires), fluids genuinely kept up all day, and daily walking. If it persists, a pharmacist can recommend suitable laxatives; don't just endure week after week of it.
"I've hit a plateau. Is it broken?"
No. Every weight loss curve flattens, including in the trials, where average loss accrued over the full 72 weeks with the steepest change early. Plateaus are your body recalibrating, not the tablet failing. The evidence-based responses are patience, a look at drift in eating habits, and a prescriber conversation about whether you've room left on the dose ladder. What plateaus are not is a reason to take extra tablets, ever.
"Can I switch to Foundayo from Mounjaro or Wegovy injections?"
This is exactly what the ATTAIN-MAINTAIN trial studied: people switching from injectable tirzepatide or semaglutide to orforglipron largely maintained their weight loss, which is the evidence base for tablets as a maintenance option after injections. How and when to switch, and at what dose, is genuinely individual, so it's a prescriber-led change, not a DIY one, and never a case of overlapping two GLP-1 medicines.
"Is the hair loss permanent?"
Hair loss is on the official list and is much discussed across all GLP-1 communities. What's typically happening is telogen effluvium: temporary shedding triggered by rapid weight loss and reduced nutrition rather than by damage to the follicles, and it usually recovers as weight stabilises. Protein intake helps. Significant or continuing loss is worth raising with your prescriber.
"Can I drink alcohol on Foundayo?"
There's no listed interaction that forbids it, but the community reports the same two realities the pharmacology predicts: alcohol hits harder on a much emptier stomach, and it aggravates nausea and reflux. Many users also find they simply want it less. If you have type 2 diabetes, alcohol on a GLP-1 needs more care around blood sugar, so ask your prescriber. Gently does it.
"How do I know if my experience is normal or a problem?"
The rule of thumb: effects that are unpleasant but improving are usually the adjustment period; effects that are severe, worsening or relentless are not. Severe or persistent stomach pain, inability to keep fluids down, allergic reactions, or the neck and thyroid red flags on our side effects map all mean prompt medical advice. And any suspected side effect can be reported straight to the MHRA via the Yellow Card scheme: with a newly approved medicine, those reports genuinely matter.
Where the conversations happen
If you want the unfiltered lived experience, communities like r/FoundayoPill are where early users compare notes daily. Read them the way you'd read any forum: brilliant for solidarity and practical tricks, unreliable for medical facts, and never a substitute for your own prescriber.